Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Urology 2, 265–266 (1 June 2005) | doi:10.1038/ncpuro0194
Intravesical immunotherapy: adverse effects on spermatogenesis
Abstract
Raviv G et al. (2005) Effects of intravesical chemotherapy and immunotherapy on semen analysis. Urology 65: 765–767 Intravesical chemotherapy or immunotherapy are common adjuvants to transurethral tumor resection in the treatment of transitional-cell carcinoma of the bladder.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
